参考文献/References:
[1] Yang G,Wang Y,Zeng Y,et al.Rapid health transition in China, 1990-2010:findings from the Global Burden of Disease Study 2010[J].Lancet,2013,381(9882):1987-2015.
[2] Wang W,Jiang B,Sun H,et al.NESS-China Investigators.Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480687 adults[J].Circulation,2017,135(8):759-771.
[3] Tsai CF,Thomas B,Sudlow CL.Epidemiology of stroke andits sub-types in Chinese vs white populations: a systematic review[J].Neurology,2013,81(3):264-272.
[4] The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333(24):1581-1587.
[5] Hacke W,Kaste M,Bluhmki E,et al.Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J].N Engl J Med,2008,359(13):1317-1329.
[6] Thomalla G,Simonsen CZ,Boutitie F,et al.MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset[J].N Engl J Med,2018,379(7):611-622.
[7] Ma H,Campbell BCV,Parsons MW,et al.Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke[J].N Engl J Med,2019,380(19):1795-1803.
[8] Del Zoppo GJ, Higashida RT, Furlan AJ, et al.PROACT:a phase Ⅱ randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism[J].Stroke,1998,29(3):4-11.
[9] Furlan A,Higashida R,Wechsler L,et al.Intra-arterial prourokinase for acute ischemic stroke. ThePROACT Ⅱ study:a randomized controlled trial.Prolyse in Acute Cerebral Thromboembolism[J].JAMA,1999,282(21):2003-2011.
[10] Ogawa A,Mori E,Minematsu K,et al.Randomized trial of intraarterial infusion ofurokinase within 6 hours of middle cerebral arterystroke:the middle cerebral artery embolism localfibrinolytic intervention trial(MELT)Japan[J].Stroke,2007,38(10):2633-2639.
[11] Lewandowski CA,Frankel M,Tomsick TA,et al.Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke:Emergency Management of Stroke(EMS)Bridging Trial[J].Stroke,1999,30(12):2598-2605.
[12] IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study[J].Stroke,2004,35(4):904-911.
[13] IMS II Trial Investigators.The Interventional Management of Stroke(IMS)II Study[J].Stroke,2007,38(7):2127-2135.
[14] Broderick JP,Palesch YY,Demchuk AM,et al.Endovascular therapyafter intravenous rt-PA versus rt-PA alonefor stroke[J].N Engl J Med,2013,368(10):893-903.
[15] Berkehemer OA,Fransen PS,Beumer D,et al.A randomized trial of intraarterial treatmentfor acute ischemic stroke[J].N Engl J Med,2015,372(1):11-20.
[16] Campbell BC,Mitchell PJ,Kleinig TJ,et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection[J].N Engl J Med,2015,372(11):1009-1018.
[17] Goyal M,Demchuk AM,Menon BK,et al.Randomized assessment of rapid endovascular treatment of ischemic stroke[J].N Engl J Med,2015,372(11):1019-1030.
[18] Saver JL,Goyal M,Bonafe A,et al.Stent-retriever thrombectomy after intravenous t-PA vs.t-PA alone in stroke[J].N Engl J Med,2015,372(24):2285-2295.
[19] Jovin TG,Chamorro A,Cobo E, et al.Thrombectomy within 8 hours after symptom onset in inchemic stroke[J].N Engl J Med,2015,372(24):2296-2306.
[20] 中国卒中学会,中国卒中学会神经介入分会,中华预防医学会卒中预防与控制专业委员会介入学组.急性缺血性卒中血管内治疗中国指南2015[J].中国卒中杂志,2015,10(7):590-606.
[21] 中国卒中学会,中国卒中学会神经介入分会,中华预防医学会卒中预防与控制专业委员会介入学组.急性缺血性卒中血管内治疗中国指南2018[J].中国卒中杂志,2018,13(7):706-729.
[22] Smith WS,Sung G,Starkman S,et al.Safety and efficacy of mechanical emhnlectomy in acute ischemic stroke:results of the MERCI trial[J].Stroke,2005,36(7):1432-1438.
[23] Smith WS,Sung G,Saver J,et al.Mechanical thrombectomy for acuteischemicstroke: final resultsof the Multi MERCI trial[J].Stroke,2008,39(4):1205-1212.
[24] Saver JL,Jahan R,Levy EI,et al.Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke(SWIFT): a randomised, parallel group, non inferiority trail[J].Lancet,2012,380(9849):1241-1249.
[25] Zaidat OO,Castonguay AC,Nogueira RG,et al.TREVO stent-retriever mechanical thrombectomy for acute ischemicstroke secondaryto large vessel occlusion registry[J].NeuroIntervent Surg,2018,10(6):516-524.
[26] Binning MJ,Bartolini B,Baxter B,et al.Trevo 2000: Results of a Large Real-World Registry for Stent Retriever for Acute Ischemic Stroke[J].J Am Heart Assoc,2018,7(24):e01086.
[27] Nogueira RG,Jadhav AP,Haussen DC,et al.Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct[J].N Engl J Med,2018,378(1):11-21.
[28] Nogueira RG,Lutsep HL,Gupta R,et al.Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke(TREVO 2):a randomised trial[J].Lancet,2012,380(9849):1231-1240.
[29] Mendonca N,Flores A,Pagola J,et al.Trevo versusSolitaire a head-to-head comparison between two heavyweights of clot retrieval[ J].J Neuroimaging,2014,24(2):167-170.
[30] Lapergue B,Blanc R,Gory B,et al.Effectof endovascular contact aspiration vs stent retrieveron revascularization in patients with acute ischemicstroke and large vessel occlusion: the ASTERrandomized clinical trial[J].JAMA,2017,318(5):443-452.
[31] Phan K,Dmytriw AA,Teng I,et al.Adirect aspiration first pass technique vs standardendovascular therapy for acute stroke:a systematicreview and meta-analysis[J].Neurosurgery,2017,83(1):19-28.
[32] Turk AS 3rd,Siddiqui A,Fifi JT,et al.Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion(COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial[J].Lancet,2019,393(10175):998-1008.
[33] Liu XF,Dai QL,Ye RD,et al.Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion(BEST): anopen-label, randomised controlled trial[J].Lancet Neurol,2020,19(2):115-122.
[34] Schonewille WJ.A randomized acute stroke trial of endovascular therapy in acute basilar artery occlusion[J].ESO-WSO,2020.
[35] Jia BX,Feng L,Liebeskind DS,et al.Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis[J/OL].J Neurointerv Surg,2018,10(8):746-750.
[36] LevyEl,SiddiquiAH,CrumlishA,et al.First foodand drug administration-approvedprospectivetrialof primaryintracranial stenting for acute stroke: SARIS(stent-assistedrecanalizationin acuteischemic stroke)[J].Stroke,2009, 40(11):3552-3556.
[37] Kappelhof M,Marquering HA,Berkhemer OA,et al.Intra-arterial treatment of patients with acute ischemic stroke and internal carotid artery occlusion:a literature review[J].J Neurointerv Surg,2015,7(1):8-15.
[38] Stracke CP,Fiehler J,Meyer L,et al.Emergency Intracranial Stenting in Acute Stroke: Predictors for Poor Outcome and for Complications[J].J Am Heart Assoc,2020,9(5):e012795.
[39] Phan K,Dmytriw AA,Lloyd D,et al.Direct endovascular thrombectomy and bridging strategies for acute ischemic stroke: a network meta-analysis[J].J Neurointerv Surg,2019,11(5):443-449.
[40] Yang PF,Zhang YW,Zhang L,et al.Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke [J].N Engl J Med,2020,382(21):1981-1993.